Does ANIDULAFUNGIN Cause Myelosuppression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Myelosuppression have been filed in association with ANIDULAFUNGIN (ERAXIS). This represents 1.6% of all adverse event reports for ANIDULAFUNGIN.
11
Reports of Myelosuppression with ANIDULAFUNGIN
1.6%
of all ANIDULAFUNGIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Myelosuppression From ANIDULAFUNGIN?
Of the 11 reports, 2 (18.2%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANIDULAFUNGIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ANIDULAFUNGIN Cause?
Drug ineffective (234)
Multiple organ dysfunction syndrome (108)
Off label use (85)
Candida infection (61)
Death (57)
Neutropenia (53)
Pneumonia (49)
Septic shock (45)
Sepsis (42)
Condition aggravated (37)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ANIDULAFUNGIN Alternatives Have Lower Myelosuppression Risk?
ANIDULAFUNGIN vs ANIFROLUMAB
ANIDULAFUNGIN vs ANIFROLUMAB-FNIA
ANIDULAFUNGIN vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN
ANIDULAFUNGIN vs ANTI-INHIBITOR COAGULANT COMPLEX
ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR HUMAN